European Ophthalmic Devices Market Outlook to 2020: Led by Alcon, Carl Zeiss Meditec, AMO and Bausch & Lomb

The increasing incidence of ocular conditions such as cataracts will drive the demand for Intraocular lenses devices and Phacoemulsification consoles, reports iData Research.

        Print
| Source: iData Research

VANCOUVER, BC, July 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, European Markets for Diagnostic and Interventional Ophthalmic Devices is expected to reach over $961 million by 2020. Growth will be driven by the increase in incidences of ocular conditions such as cataracts, glaucoma and refractive problems. These conditions will drive the demand for ophthalmic diagnostic and interventional equipment, specifically intraocular lenses (IOLs) and Phacoemulsification consoles. Main players fuelling this market include Alcon, AMO, Carl Zeiss Meditec, Bausch & Lomb and STAAR Surgical.

Cataracts are one of the leading causes of reversible blindness and visual impairment worldwide. The World Health Organization estimated that by 2020, 32 million cataract operations will be performed globally. "Phacoemulsification, is the preferred and most common cataract surgery technique because it requires a smaller incision for cataract removal. The small incision necessitates the insertion of foldable artificial lenses known as intraocular lenses," says Dr. Zamanian, CEO of iData.

In recent years, there have been a number of ground-breaking technological advances within the field of cataract surgery including:

Phacoemulsification devices: An important innovation is the use of lasers for Phacoemulsification. The advantage of this technique, which is known as Femto-Phacoemulsification, is more precise surgery, less invasiveness and the ability to use new types of IOLs.

Femtosecond lasers: These devices are designed to replace and augment several stages in the cataract surgery process. They are capable of making precise surgical incisions, performing capsulorhexis, lens fragmentation and facilitating limbal relaxing incisions. Alcon's LenSx® was the first approved femtosecond laser for cataract surgery. Currently it is used primarily in premium sites; the main customers are cataract surgeons who also do corneal refractive surgery.

Procedure planning software for cataract surgery: Introduced in 2013 by Carl Zeiss Meditec (CALLISTO eye®) and Alcon (VERION™ Image Guided System). The goal of these systems is to improve refractive outcomes during cataract surgery by integrating different pieces of surgical equipment with diagnostic patient data. Because the system is modular, it can be customized to meet the needs and equipment of specific clinics.

For Further Information

The global report series on the Markets for Ophthalmic Devices is available for the U.S., and 15 counties in Europe. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success strategies in each market and segment.

The reports cover Optical coherence tomography (OCT), Fundus cameras, Slit lamps, Perimetry, Tonometer, Ophthalmic ultrasound, Corneal topography, Wavefront aberrometry, Phacoemulsification console, Intraocular lenses (IOLs) and Phakic lenses.

Receive a free synopsis of the 2014 European Markets for Ophthalmic Devices.

About iData Research

iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anaesthesiology, Wound Management, Orthopaedics, Cardiovascular, Ophthalmic, Endoscopy, Gynecology, Urology and more.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/07/prweb12000059.htm

iData Research
Caroline Lau

+1 604-266-6933 Ext: 215